Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”) today
announced results for the third quarter ended September 30,
2022.
Third Quarter 2022
Highlights
- Third quarter 2022 net revenue
declined 2.6% to $66.3 million, compared to $68.1 million in the
third quarter of 2021.
- Third quarter 2022 gross margin
declined to 45.5%, compared to 50.2% in the third quarter of 2021,
primarily due to the liquidation of high priced excess
inventory.
- Third quarter 2022 contribution
margin declined to 1.1% from 12.1% in the third quarter of 2021,
primarily due to the liquidation of high priced excess
inventory.
- Third quarter 2022 operating loss
of $(108.9) million increased, compared to a loss of $(7.5) million
in the third quarter of 2021. Third quarter 2022 operating loss
includes a gain of $0.8 million from the change in fair value of
earn-out liabilities, a non-cash loss of $(90.9) million from the
impairment on goodwill, a non-cash loss of $(3.1) million on the
impairment on intangibles and $(2.9) million of non-cash stock
compensation while third quarter 2021 operating loss included a
gain of $4.2 million from the change in fair value of earn-out
liabilities and $(9.6) million of non-cash stock compensation.
- Third quarter 2022 net loss of
$(116.9) million increased from $(110.6) million in the third
quarter of 2021. Third quarter 2022 net loss includes a gain of
$5.5 million in net charges from the changes in fair value of
warrants, a loss of $(12.8) million from the derivative related to
offering of common stock, $(2.9) million of non-cash stock
compensation, a gain of $0.8 million from the change in fair value
of earn-out liabilities, a non-cash loss of $(90.9) million from
the impairment on goodwill, and a non-cash loss of $(3.1) million
on the impairment on intangibles, while third quarter 2021 included
a loss of $(107.0) million from extinguishment of debt, a gain of
$8.1 million from the change in fair value of warrants, and a gain
of $1.4 million associated with a derivative liability from our
term loan, a gain of $4.2 million from the change in fair value of
earn-out liabilities and $(9.6) million of non-cash stock
compensation.
- Third quarter 2022 adjusted EBITDA
of $(9.1) million declined as compared to $0.7 million in the third
quarter of 2021.
- Launched one new product in the
third quarter of 2022 compared with zero new products launched in
the third quarter of 2021.
- Total cash balance at September 30,
2022 was $26.0 million.
“Shipping costs have cast a cloud over ecommerce
for an extended period, but last week we loaded containers from
China at approximately a 90 percent discount to the costs we
incurred in the second half of 2021,” commented Yaniv Sarig, CEO of
Aterian. "With these costs continuing to normalize, we can begin
transitioning from defense to offense. We plan to close the year by
continuing what we did in this past quarter: aggressively
liquidating higher cost inventory, extending market share of our
leading products, and charting a path to sustainable contribution
margins and positive Adjusted EBITDA. The austere operating
conditions arising out of the pandemic have increased the universe
of potential M&A targets, and we continue to evaluate
attractively valued opportunities.”
Fourth Quarter 2022 OutlookFor
the fourth quarter of 2022, taking into account the current global
environment and rising inflation, we believe that net revenue will
be between $45 million and $55 million.
Non-GAAP Financial MeasuresFor
more information on our non-GAAP financial measures and a
reconciliation of GAAP to non-GAAP measures, please see the
“Non-GAAP Financial Measures and Reconciliations” section below.
The most directly comparable financial measure presented in
accordance with GAAP to EBITDA and Adjusted EBITDA is net loss. We
are unable to reconcile the forward-looking statements of EBITDA
and Adjusted EBITDA in this press release to their nearest GAAP
measures because the nearest GAAP financial measures are not
accessible on a forward-looking basis and reconciling information
is not available without unreasonable effort.
Webcast and Conference Call
InformationAterian will host a conference call to discuss
financial results today, November 8, 2022, at 5:00 p.m. Eastern
Time, which will be accessible by telephone and the internet. To
access the call, participants from within the U.S. should dial
(833) 636-1351 and participants from outside the U.S. should dial
(412) 902-4267 and ask to be joined into the Aterian, Inc. call.
Participants may also access the call through a live webcast at
https://ir.aterian.io. The archived online replay will be available
for a limited time after the call in the Investors Relations
section of the Aterian website.
About Aterian, Inc.Aterian,
Inc. (Nasdaq: ATER) is a leading technology-enabled consumer
product platform that builds, acquires, and partners with
best-in-class e-commerce brands by harnessing proprietary software
and an agile supply chain to create top selling consumer products.
The Company’s cloud-based platform, Artificial Intelligence
Marketplace Ecommerce Engine (AIMEE™), leverages machine learning,
natural language processing and data analytics to streamline the
management of products at scale across the world's largest online
marketplaces with a focus on Amazon, Shopify and Walmart. Aterian
has thousands of SKUs across its many owned and operated brands and
sells products in multiple categories, including home and kitchen
appliances, health and wellness, beauty and consumer
electronics.
Forward Looking StatementsAll
statements other than statements of historical facts included in
this press release that address activities, events or developments
that we expect, believe or anticipate will or may occur in the
future are forward-looking statements including, in particular, the
statements about our expected net revenue for the fourth quarter of
2022; regarding our target of achieving adjusted EBITDA
profitability in the second half of 2023; our ability to extend
market share and reduce costs; expected changes in the cost of
shipping containers and shipping rates; our expectations regarding
the transition of our business strategy from offense to defense;
our expectations regarding contribution margin and adjusted EBITDA;
our ability to manage our inventory, including through liquidation
of inventory; and our expectations around our M&A
opportunities. These forward-looking statements are based on
management’s current expectations and beliefs and are subject to a
number of risks and uncertainties and other factors, all of which
are difficult to predict and many of which are beyond our control
and could cause actual results to differ materially and adversely
from those described in the forward-looking statements. These risks
include, but are not limited to, those related to the global
shipping disruptions, our ability to continue as a going concern,
our ability to meet financial covenants with our lenders, our
ability to create operating leverage and efficiency when
integrating companies that we acquire or have acquired, including
through the use of our team’s expertise, the economies of scale of
our supply chain and automation driven by our platform; those
related to our ability to grow internationally and through the
launch of products under our brands and the acquisition of
additional brands; those related to the impact of COVID-19, the war
in the Ukraine, the rising tensions between China and Taiwan and
other macroeconomic factors, including their impact on consumer
demand, our cash flows, financial condition, forecasting and
revenue growth rate; our supply chain including sourcing,
manufacturing, warehousing and fulfillment; our ability to manage
expenses, working capital and capital expenditures efficiently; our
business model and our technology platform; the impact of
intangible assets such as goodwill, and other impairments;
disruptions to the Company's information technology systems,
including but not limited to potential or actual security breaches
of systems protecting consumer and employee information or other
types of cybercrimes or cybersecurity attacks; our ability to
disrupt the consumer products industry; our ability to maintain and
grow market share in existing and new product categories; our
ability to generate profitability and stockholder value;
international tariffs and trade measures; inventory management,
product liability claims, recalls or other safety and regulatory
concerns; reliance on third party online marketplaces; seasonal and
quarterly variations in our revenue and expenses; acquisitions of
other companies and technologies and our ability to successfully
integrate such companies and technologies with our business; our
ability to continue to access debt and equity capital (including on
terms advantageous to the Company) and the extent of our leverage;
and other factors discussed in the “Risk Factors” section of our
most recent periodic reports filed with the Securities and Exchange
Commission (“SEC”), all of which you may obtain for free on the
SEC’s website at www.sec.gov.
Although we believe that the expectations
reflected in our forward-looking statements are reasonable, we do
not know whether our expectations will prove correct. You are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, even if
subsequently made available by us on our website or otherwise. We
do not undertake any obligation to update, amend or clarify these
forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under
applicable securities laws.
ATERIAN, INC.Condensed
Consolidated Balance
Sheets(Unaudited)(in thousands,
except share and per share data)
|
|
December 31, 2021 |
|
|
September 30, 2022 |
|
ASSETS |
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
Cash |
|
$ |
30,317 |
|
|
$ |
25,997 |
|
Accounts receivable—net |
|
|
10,478 |
|
|
|
4,933 |
|
Inventory |
|
|
63,045 |
|
|
|
60,457 |
|
Prepaid and other current assets |
|
|
21,034 |
|
|
|
10,459 |
|
Total current assets |
|
|
124,874 |
|
|
|
101,846 |
|
PROPERTY AND EQUIPMENT—net |
|
|
1,254 |
|
|
|
856 |
|
GOODWILL—net |
|
|
119,941 |
|
|
|
— |
|
OTHER INTANGIBLES—net |
|
|
64,955 |
|
|
|
56,265 |
|
OTHER NON-CURRENT ASSETS |
|
|
2,546 |
|
|
|
2,564 |
|
TOTAL ASSETS |
|
$ |
313,570 |
|
|
$ |
161,531 |
|
LIABILITIES AND
STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
Credit facility |
|
$ |
32,845 |
|
|
$ |
23,919 |
|
Accounts payable |
|
|
21,716 |
|
|
|
13,491 |
|
Seller notes |
|
|
7,577 |
|
|
|
2,326 |
|
Contingent earn-out liability |
|
|
3,983 |
|
|
|
— |
|
Warrant liability |
|
|
— |
|
|
|
6,308 |
|
Accrued and other current liabilities |
|
|
17,621 |
|
|
|
14,533 |
|
Total current liabilities |
|
|
83,742 |
|
|
|
60,577 |
|
OTHER LIABILITIES |
|
|
360 |
|
|
|
1,673 |
|
CONTINGENT EARN-OUT
LIABILITY |
|
|
5,240 |
|
|
|
— |
|
Total liabilities |
|
|
89,342 |
|
|
|
62,250 |
|
COMMITMENTS AND
CONTINGENCIES |
|
|
|
|
|
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
Common stock, par value $0.0001
per share—500,000,000 shares authorized and 55,090,237 shares
outstanding at December 31, 2021; 500,000,000 shares
authorized and 69,540,749 shares outstanding at September 30,
2022 |
|
|
5 |
|
|
|
7 |
|
Additional paid-in capital |
|
|
653,650 |
|
|
|
705,775 |
|
Accumulated deficit |
|
|
(428,959 |
) |
|
|
(604,946 |
) |
Accumulated other comprehensive loss |
|
|
(468 |
) |
|
|
(1,555 |
) |
Total stockholders’ equity |
|
|
224,228 |
|
|
|
99,281 |
|
TOTAL LIABILITIES AND
STOCKHOLDERS’ EQUITY |
|
$ |
313,570 |
|
|
$ |
161,531 |
|
See notes to condensed consolidated financial statements.
ATERIAN, INC. Condensed
Consolidated Statements of Operations
(Unaudited) (in thousands, except share
and per share data)
|
|
Three Months
EndedSeptember 30, |
|
|
Nine Months
EndedSeptember 30, |
|
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
NET REVENUE |
|
$ |
68,121 |
|
|
$ |
66,326 |
|
|
$ |
184,446 |
|
|
$ |
166,268 |
|
COST OF GOODS SOLD |
|
|
33,946 |
|
|
|
36,135 |
|
|
|
91,464 |
|
|
|
81,118 |
|
GROSS PROFIT |
|
|
34,175 |
|
|
|
30,191 |
|
|
|
92,982 |
|
|
|
85,150 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
32,337 |
|
|
|
33,792 |
|
|
|
96,716 |
|
|
|
88,632 |
|
Research and development |
|
|
2,767 |
|
|
|
1,706 |
|
|
|
7,220 |
|
|
|
4,582 |
|
General and administrative |
|
|
10,843 |
|
|
|
10,369 |
|
|
|
31,807 |
|
|
|
29,481 |
|
Impairment loss on goodwill |
|
|
— |
|
|
|
90,921 |
|
|
|
— |
|
|
|
119,941 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
(4,245 |
) |
|
|
(774 |
) |
|
|
(11,949 |
) |
|
|
(5,240 |
) |
TOTAL OPERATING EXPENSES: |
|
|
41,702 |
|
|
|
139,132 |
|
|
|
123,794 |
|
|
|
240,514 |
|
OPERATING LOSS |
|
|
(7,527 |
) |
|
|
(108,941 |
) |
|
|
(30,812 |
) |
|
|
(155,364 |
) |
INTEREST EXPENSE—net |
|
|
2,786 |
|
|
|
904 |
|
|
|
11,877 |
|
|
|
2,043 |
|
GAIN ON EXTINGUISHMENT OF SELLER
NOTE |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
LOSS ON INITIAL ISSUANCE OF
EQUITY |
|
|
— |
|
|
|
12,834 |
|
|
|
— |
|
|
|
18,669 |
|
CHANGE IN FAIR VALUE OF
DERIVATIVE LIABILITY |
|
|
1,360 |
|
|
|
— |
|
|
|
3,254 |
|
|
|
— |
|
LOSS ON EXTINGUISHMENT OF
DEBT |
|
|
106,991 |
|
|
|
— |
|
|
|
136,763 |
|
|
|
— |
|
CHANGE IN FAIR VALUE OF WARRANT
LIABILITY |
|
|
(8,134 |
) |
|
|
(5,528 |
) |
|
|
26,455 |
|
|
|
2,365 |
|
LOSS ON INITIAL ISSUANCE OF
WARRANT |
|
|
— |
|
|
|
— |
|
|
|
20,147 |
|
|
|
— |
|
OTHER EXPENSE (INCOME) |
|
|
5 |
|
|
|
(174 |
) |
|
|
43 |
|
|
|
(199 |
) |
LOSS BEFORE INCOME TAXES |
|
|
(110,535 |
) |
|
|
(116,977 |
) |
|
|
(229,351 |
) |
|
|
(176,230 |
) |
PROVISION FOR (BENEFIT FROM)
INCOME TAXES |
|
|
21 |
|
|
|
(75 |
) |
|
|
64 |
|
|
|
(243 |
) |
NET LOSS |
|
$ |
(110,556 |
) |
|
$ |
(116,902 |
) |
|
$ |
(229,415 |
) |
|
$ |
(175,987 |
) |
Net loss per share, basic and
diluted |
|
$ |
(3.13 |
) |
|
$ |
(1.81 |
) |
|
$ |
(7.55 |
) |
|
$ |
(2.78 |
) |
Weighted-average number of shares
outstanding, basic and diluted |
|
|
35,359,999 |
|
|
|
64,648,650 |
|
|
|
30,383,375 |
|
|
|
63,397,196 |
|
See notes to condensed consolidated financial statements.
ATERIAN, INC. Condensed
Consolidated Statements of Cash
Flows(Unaudited) (in
thousands)
|
|
Nine Months Ended September 30, |
|
|
|
2021 |
|
|
2022 |
|
OPERATING ACTIVITIES: |
|
|
|
|
|
|
Net loss |
|
$ |
(229,415 |
) |
|
$ |
(175,987 |
) |
Adjustments to reconcile net loss
to net cash used in operating activities: |
|
|
|
|
|
|
Depreciation and amortization |
|
|
4,757 |
|
|
|
5,763 |
|
Provision for sales returns |
|
|
398 |
|
|
|
134 |
|
Amortization of deferred financing costs and debt discounts |
|
|
7,730 |
|
|
|
321 |
|
Issuance of common stock |
|
|
— |
|
|
|
43 |
|
Stock-based compensation |
|
|
21,330 |
|
|
|
11,854 |
|
Gain from increase of contingent earn-out liability fair value |
|
|
(11,949 |
) |
|
|
(5,240 |
) |
Loss in connection with the change in warrant fair value |
|
|
26,455 |
|
|
|
2,365 |
|
Loss from extinguishment of High Trail December 2020 and February
2021 Term Loan |
|
|
28,240 |
|
|
|
— |
|
Loss from extinguishment of High Trail April 2021 Term Loan |
|
|
106,991 |
|
|
|
— |
|
Loss from embedded derivative related to term loan |
|
|
3,254 |
|
|
|
— |
|
Loss from extinguishment of Credit Facility |
|
|
1,532 |
|
|
|
— |
|
Loss on initial issuance of warrant |
|
|
20,147 |
|
|
|
— |
|
Gain in connection with settlement of note payable |
|
|
— |
|
|
|
(2,012 |
) |
Loss on initial issuance of equity |
|
|
— |
|
|
|
18,669 |
|
Impairment loss on goodwill |
|
|
— |
|
|
|
119,941 |
|
Impairment loss on intangibles |
|
|
|
|
|
3,118 |
|
Allowance for doubtful accounts and other |
|
|
4,597 |
|
|
|
219 |
|
Changes in assets and liabilities: |
|
|
|
|
|
|
Accounts receivable |
|
|
(3,765 |
) |
|
|
5,326 |
|
Inventory |
|
|
(27,531 |
) |
|
|
2,588 |
|
Prepaid and other current assets |
|
|
(7,219 |
) |
|
|
3,351 |
|
Accounts payable, accrued and other liabilities |
|
|
13,999 |
|
|
|
(9,994 |
) |
Cash used in operating activities |
|
|
(40,449 |
) |
|
|
(19,541 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
|
|
Purchase of fixed assets |
|
|
(14 |
) |
|
|
(29 |
) |
Purchase of Healing Solutions assets |
|
|
(15,250 |
) |
|
|
— |
|
Purchase of Photo Paper Direct, net of cash acquired |
|
|
(10,583 |
) |
|
|
— |
|
Purchase of Squatty Potty assets |
|
|
(19,040 |
) |
|
|
— |
|
Cash used in investing activities |
|
|
(44,887 |
) |
|
|
(29 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
|
|
Proceeds from warrant exercise |
|
|
9,051 |
|
|
|
— |
|
Proceeds from cancellation of warrant |
|
|
16,957 |
|
|
|
— |
|
Proceeds from equity offering, net of issuance costs |
|
|
36,735 |
|
|
|
— |
|
Proceeds from equity offering |
|
|
8,749 |
|
|
|
27,007 |
|
Repayments on note payable to Smash |
|
|
(9,254 |
) |
|
|
(2,868 |
) |
Borrowings from MidCap credit facility |
|
|
14,630 |
|
|
|
107,678 |
|
Repayments for MidCap credit facility |
|
|
(28,274 |
) |
|
|
(116,924 |
) |
Deferred financing costs from MidCap credit facility |
|
|
(151 |
) |
|
|
— |
|
Repayments for High Trail December 2020 Note and February 2021
Note |
|
|
(59,500 |
) |
|
|
— |
|
Borrowings from High Trail February 2021 Note and warrants |
|
|
14,025 |
|
|
|
— |
|
Repayments for High Trail April 2021 Note |
|
|
(10,139 |
) |
|
|
— |
|
Borrowings from High Trail April 2021 Note and warrants |
|
|
110,000 |
|
|
|
|
Debt issuance costs from High Trail February 2021 Note |
|
|
(1,462 |
) |
|
|
— |
|
Debt issuance costs from High Trail April 2021 Note |
|
|
(2,202 |
) |
|
|
— |
|
Payment for squatty earn-out |
|
|
(3,988 |
) |
|
|
(3,983 |
) |
Insurance obligation payments |
|
|
(2,329 |
) |
|
|
(1,778 |
) |
Insurance financing proceeds |
|
|
2,424 |
|
|
|
2,099 |
|
Cash provided by financing activities |
|
|
95,272 |
|
|
|
11,231 |
|
EFFECT OF EXCHANGE RATE ON
CASH |
|
|
(434 |
) |
|
|
(936 |
) |
NET CHANGE IN CASH AND RESTRICTED
CASH FOR PERIOD |
|
|
9,502 |
|
|
|
(9,275 |
) |
CASH AND RESTRICTED CASH AT
BEGINNING OF PERIOD |
|
|
30,097 |
|
|
|
38,315 |
|
CASH AND RESTRICTED CASH AT END
OF PERIOD |
|
$ |
39,599 |
|
|
$ |
29,040 |
|
RECONCILIATION OF CASH AND
RESTRICTED CASH |
|
|
|
|
|
|
CASH |
|
$ |
37,470 |
|
|
$ |
25,997 |
|
RESTRICTED CASH—Prepaid and other
assets |
|
|
2,000 |
|
|
|
2,914 |
|
RESTRICTED CASH—Other non-current
assets |
|
|
129 |
|
|
|
129 |
|
TOTAL CASH AND RESTRICTED
CASH |
|
$ |
39,599 |
|
|
$ |
29,040 |
|
|
ATERIAN, INC. Condensed
Consolidated Statements of Cash
Flows(Unaudited) (in
thousands)
SUPPLEMENTAL DISCLOSURES OF CASH
FLOW INFORMATION |
|
|
|
|
|
Cash paid for interest |
|
$ |
4,989 |
|
|
$ |
1,409 |
Cash paid for taxes |
|
$ |
41 |
|
|
$ |
58 |
Non-cash consideration paid to
contractors |
|
$ |
4,032 |
|
|
$ |
1,137 |
Modification of warrants between
equity and liability |
|
$ |
75,826 |
|
|
$ |
— |
NON-CASH INVESTING AND FINANCING
ACTIVITIES: |
|
|
|
|
|
Original issue discount |
|
$ |
2,475 |
|
|
$ |
— |
Fair value of contingent
consideration |
|
$ |
20,971 |
|
|
$ |
— |
Discount of debt relating to
warrants issuance |
|
$ |
50,695 |
|
|
$ |
— |
Notes Payable of acquisition |
|
$ |
16,550 |
|
|
$ |
— |
Issuance of common stock in
connection with Healing Solutions and Photo Paper Direct
acquisitions |
|
$ |
50,529 |
|
|
$ |
— |
Issuance of common stock - debt
repayment |
|
$ |
125,562 |
|
|
$ |
— |
Issuance of common stock related
to exercise of warrants |
|
$ |
— |
|
|
$ |
767 |
Fair value of warrants issued in
connection with equity offering |
|
$ |
— |
|
|
$ |
18,982 |
Issuance of Common Stock |
|
$ |
— |
|
|
$ |
43 |
Exercise of prefunded
warrants |
|
$ |
— |
|
|
$ |
15,039 |
See notes to condensed consolidated financial statements.
Non-GAAP Financial Measures
In addition to disclosing financial measures
prepared in accordance with U.S. generally accepted accounting
principles (“GAAP”), this press release and accompanying tables
include certain non-GAAP financial measures. The non-GAAP financial
measures contained herein are a supplement to the corresponding
financial measures prepared in accordance with U.S. GAAP. The
non-GAAP financial measures presented exclude the items described
below. Management believes that adjustments for these items assist
investors in making comparisons of period-to-period operating
results. Furthermore, management also believes that these items are
not indicative of our on-going core operating performance. These
non-GAAP financial measures have certain limitations in that they
do not reflect all of the costs associated with the operations of
our business as determined in accordance with GAAP.
Therefore, investors should consider non-GAAP
financial measures in addition to, and not as a substitute for, or
as superior to, measures of financial performance prepared in
accordance with GAAP. The non-GAAP financial measures presented by
us may be different from the non-GAAP financial measures used by
other companies.
We have presented the following non-GAAP
measures to assist investors in understanding our core net
operating results on an on-going basis: (i) Contribution Margin;
(ii) Contribution margin as a percentage of net revenue; (iii)
EBITDA (iv) Adjusted EBITDA; and (v) Adjusted EBITDA as a
percentage of net revenue. These non-GAAP financial measures may
also assist investors in making comparisons of our core operating
results with those of other companies.
As used herein, Contribution margin represents
gross profit less amortization of inventory step-up from
acquisitions (included in cost of goods sold) and e-commerce
platform commissions, online advertising, selling and logistics
expenses (included in sales and distribution expenses). As
used herein, Contribution margin as a percentage of net revenue
represents Contribution margin divided by net revenue. As used
herein, EBITDA represents net loss plus depreciation and
amortization, interest expense, net and provision for income taxes.
As used herein, Adjusted EBITDA represents EBITDA plus stock-based
compensation expense, changes in fair-market value of earn-outs,
amortization of inventory step-up from acquisitions (included in
cost of goods sold), changes in fair-market value of warrant
liability, professional fees and transition costs related to
acquisitions, loss from extinguishment of debt, impairment of
goodwill, loss on initial issuance of equity, litigation reserve
and other expenses, net. As used herein, Adjusted EBITDA as a
percentage of net revenue represents Adjusted EBITDA divided by net
revenue. Contribution margin, EBITDA and Adjusted EBITDA do not
represent and should not be considered as alternatives to loss from
operations or net loss, as determined under GAAP.
We present Contribution margin and Contribution
margin as a percentage of net revenue, as we believe each of these
measures provides an additional metric to evaluate our operations
and, when considered with both our GAAP results and the
reconciliation to gross profit, provides useful supplemental
information for investors. Specifically, Contribution margin
and Contribution margin as a percentage of net revenue are two
of our key metrics in running our business. All product
decisions made by us, from the approval of launching a new product
and to the liquidation of a product at the end of its life cycle,
are measured primarily from Contribution margin and/or Contribution
margin as a percentage of net revenue. Further, we believe
these measures provide improved transparency to our stockholders to
determine the performance of our products prior to fixed costs as
opposed to referencing gross profit alone.
In the reconciliation to calculate contribution
margin, we add e-commerce platform commissions, online advertising,
selling and logistics expenses (“sales and distribution variable
expense”), to gross margin to inform users of our financial
statements of what our product profitability is at each period
prior to fixed costs (such as sales and distribution expenses such
as salaries as well as research and development expenses and
general administrative expenses). By excluding these fixed
costs, we believe this allows users of our financial statements to
understand our products’ performance and allows them to measure our
products’ performance over time.
We present EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue because we believe each of
these measures provides an additional metric to evaluate our
operations and, when considered with both our GAAP results and the
reconciliation to net loss, provide useful supplemental information
for investors. We use these measures with financial measures
prepared in accordance with GAAP, such as sales and gross margins,
to assess our historical and prospective operating performance, to
provide meaningful comparisons of operating performance across
periods, to enhance our understanding of our operating performance
and to compare our performance to that of our peers and
competitors. We believe EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue are useful to investors in
assessing the operating performance of our business without the
effect of non-cash items.
Contribution margin, Contribution margin as a
percentage of net revenue, EBITDA, Adjusted EBITDA and Adjusted
EBITDA as a percentage of net revenue should not be considered in
isolation or as alternatives to net loss, loss from operations or
any other measure of financial performance calculated and
prescribed in accordance with GAAP. Neither EBITDA, Adjusted EBITDA
or Adjusted EBITDA as a percentage of net revenue should be
considered a measure of discretionary cash available to us to
invest in the growth of our business. Our Contribution margin,
Contribution margin as a percentage of net revenue, EBITDA,
Adjusted EBITDA and Adjusted EBITDA as a percentage of net revenue
may not be comparable to similarly titled measures in other
organizations because other organizations may not calculate
Contribution margin, Contribution margin as a percentage of net
revenue, EBITDA, Adjusted EBITDA or Adjusted EBITDA as a percentage
of net revenue in the same manner as we do. Our presentation of
Contribution margin and Adjusted EBITDA should not be construed as
an inference that our future results will be unaffected by the
expenses that are excluded from such terms or by unusual
or non-recurring items.
We recognize that EBITDA, Adjusted EBITDA and
Adjusted EBITDA as a percentage of net revenue, have limitations as
analytical financial measures. For example, neither EBITDA nor
Adjusted EBITDA reflects:
- our capital
expenditures or future requirements for capital expenditures or
mergers and acquisitions;
- the interest expense or the cash
requirements necessary to service interest expense or principal
payments, associated with indebtedness;
- depreciation and amortization,
which are non-cash charges, although the assets being
depreciated and amortized will likely have to be replaced in the
future, or any cash requirements for the replacement of
assets;
- changes in cash requirements for
our working capital needs; or
- changes in fair value of contingent
earn-out liabilities, warrant liabilities, and amortization of
inventory step-up from acquisitions (included in cost of goods
sold).
Additionally, Adjusted EBITDA
excludes non-cash expense for stock-based compensation,
which is and is expected to remain a key element of our overall
long-term incentive compensation package.We also recognize that
Contribution margin and Contribution margin as a percentage of net
revenue have limitations as analytical financial measures. For
example, Contribution margin does not reflect:
- general and
administrative expense necessary to operate our
business;
- research and development expenses
necessary for the development, operation and support of our
software platform;
- the fixed costs portion of our
sales and distribution expenses including stock-based compensation
expense; or
- changes in fair value of contingent
earn-out liabilities, warrant liabilities, and amortization of
inventory step-up from acquisitions (included in cost of goods
sold).
Adjusted EBITDA
EBITDA represents net loss plus depreciation and
amortization, interest expense, net and provision for income
taxes. Adjusted EBITDA represents EBITDA plus
stock-based compensation expense, changes in fair-market value of
earn-outs, amortization of inventory step-up from acquisitions
(included in cost of goods sold), change in fair-market value of
warrant liability, professional fees and transition costs related
to acquisitions, loss from extinguishment of debt, impairment of
goodwill, loss on initial issuance of equity, litigation reserve
and other expenses, net. As used herein, Adjusted EBITDA
as a percentage of net revenue represents Adjusted EBITDA divided
by net revenue.
The following table provides a reconciliation of
EBITDA and Adjusted EBITDA to net loss, which is the most directly
comparable financial measure presented in accordance with GAAP:
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
|
(in thousands, except percentages) |
|
Net loss |
|
$ |
(110,556 |
) |
|
$ |
(116,902 |
) |
|
$ |
(229,415 |
) |
|
$ |
(175,987 |
) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
Provision for (benefit from)
income taxes |
|
|
21 |
|
|
|
(75 |
) |
|
|
64 |
|
|
|
(243 |
) |
Interest expense, net |
|
|
2,786 |
|
|
|
904 |
|
|
|
11,877 |
|
|
|
2,043 |
|
Depreciation and
amortization |
|
|
1,872 |
|
|
|
1,869 |
|
|
|
4,757 |
|
|
|
5,763 |
|
EBITDA |
|
|
(105,877 |
) |
|
|
(114,204 |
) |
|
|
(212,717 |
) |
|
|
(168,424 |
) |
Other expense (income), net |
|
|
5 |
|
|
|
(174 |
) |
|
|
43 |
|
|
|
(199 |
) |
Impairment loss on goodwill |
|
|
— |
|
|
|
90,921 |
|
|
|
— |
|
|
|
119,941 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
|
3,118 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
(4,245 |
) |
|
|
(774 |
) |
|
|
(11,949 |
) |
|
|
(5,240 |
) |
Amortization of inventory step-up
from acquisitions (included in cost of goods sold) |
|
|
875 |
|
|
|
— |
|
|
|
4,916 |
|
|
|
— |
|
Gain on extinguishment of seller
note |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,012 |
) |
Loss on initial issuance of
equity |
|
|
— |
|
|
|
12,834 |
|
|
|
— |
|
|
|
18,669 |
|
Change in fair value of
derivative liability |
|
|
1,360 |
|
|
|
— |
|
|
|
3,254 |
|
|
|
— |
|
Loss on extinguishment of
debt |
|
|
106,991 |
|
|
|
— |
|
|
|
136,763 |
|
|
|
— |
|
Change in fair market value of
warrant liability |
|
|
(8,134 |
) |
|
|
(5,528 |
) |
|
|
26,455 |
|
|
|
2,365 |
|
Loss on initial issuance of
warrant |
|
|
— |
|
|
|
— |
|
|
|
20,147 |
|
|
|
— |
|
Professional fees related to
acquisitions |
|
|
53 |
|
|
|
— |
|
|
|
1,450 |
|
|
|
— |
|
Litigation reserve |
|
|
— |
|
|
|
1,800 |
|
|
|
— |
|
|
|
2,600 |
|
Transition cost from
acquisitions |
|
|
130 |
|
|
|
— |
|
|
|
1,314 |
|
|
|
— |
|
Transition cost from Photo Paper
Direct acquisition |
|
|
— |
|
|
|
— |
|
|
|
696 |
|
|
|
— |
|
Reserve on dispute with PPE
supplier |
|
|
— |
|
|
|
— |
|
|
|
4,100 |
|
|
|
— |
|
Stock-based compensation
expense |
|
|
9,570 |
|
|
|
2,943 |
|
|
|
21,330 |
|
|
|
11,854 |
|
Adjusted EBITDA |
|
$ |
728 |
|
|
$ |
(9,064 |
) |
|
$ |
(4,198 |
) |
|
$ |
(17,328 |
) |
Net loss as a percentage of net
revenue |
|
|
(162.3 |
)% |
|
|
(176.3 |
)% |
|
|
(124.4 |
)% |
|
|
(105.8 |
)% |
Adjusted EBITDA as a percentage
of net revenue |
|
|
1.1 |
% |
|
|
(13.7 |
)% |
|
|
(2.3 |
)% |
|
|
(10.4 |
)% |
Contribution MarginContribution margin
represents gross profit less amortization of inventory step-up from
acquisitions (included in cost of goods sold) and e-commerce
platform commissions, online advertising, selling and logistics
expenses (included in sales and distribution expenses).
Contribution margin as a percentage of net revenue represents
Contribution margin divided by net revenue. The following table
provides a reconciliation of Contribution margin to gross profit
and Contribution margin as a percentage of net revenue to gross
profit as a percentage of net revenue, which are the most directly
comparable financial measures presented in accordance with
GAAP.
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
|
(in thousands, except percentages) |
|
Gross Profit |
|
$ |
34,175 |
|
|
$ |
30,191 |
|
|
$ |
92,982 |
|
|
$ |
85,150 |
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of inventory step-up
from acquisitions (included in cost of goods sold) |
|
|
875 |
|
|
|
— |
|
|
|
4,916 |
|
|
|
— |
|
Less: |
|
|
|
|
|
|
|
|
|
|
|
|
E-commerce platform commissions,
online advertising, selling and logistics expenses |
|
|
(26,818 |
) |
|
|
(29,448 |
) |
|
|
(77,870 |
) |
|
|
(74,927 |
) |
Contribution margin |
|
$ |
8,232 |
|
|
$ |
743 |
|
|
$ |
20,028 |
|
|
$ |
10,223 |
|
Gross Profit as a percentage of
net revenue |
|
|
50.2 |
% |
|
|
45.5 |
% |
|
|
50.4 |
% |
|
|
51.2 |
% |
Contribution margin as a
percentage of net revenue |
|
|
12.1 |
% |
|
|
1.1 |
% |
|
|
10.9 |
% |
|
|
6.1 |
% |
Each of our products typically goes through the
Launch phase and depending on its level of success is moved to one
of the other phases as further described below:
- Launch phase:
During this phase, we leverage our technology to target
opportunities identified using AIMEE (Artificial Intelligence
Marketplace e-Commerce Engine) and other sources. This phase also
includes revenue from new product variations and relaunches. During
this period of time, due to the combination of discounts and
investment in marketing, our net margin for a product could be as
low as approximately negative 35%. Net margin is calculated by
taking net revenue less the cost of goods sold, less fulfillment,
online advertising and selling expenses. These costs primarily
reflect the estimated variable costs related to the sale of a
product.
- Sustain phase: Our
goal is for every product we launch to enter the sustain phase and
become profitable, with a target average of positive 15% net
margin, within approximately three months of launch on average. Net
margin primarily reflects a combination of manual and automated
adjustments in price and marketing spend.
- Liquidate phase: If
a product does not enter the sustain phase or if the customer
satisfaction of the product (i.e., ratings) is not satisfactory,
then it will go to the liquidate phase and we will sell through the
remaining inventory. Products can also be liquidated as part of
inventory normalization especially when steep discounts are
required.
The following tables break out our third quarter
2021 and 2022 results of operations by our product phases:
|
|
Three months ended September 30, 2021 (in thousands)
(unaudited) |
|
|
Sustain |
|
Launch |
|
Liquidate/Other |
|
Fixed Costs |
|
Stock-based compensation expense |
|
Total |
NET REVENUE |
|
$ |
59,754 |
|
$ |
5,336 |
|
$ |
3,031 |
|
|
$ |
— |
|
|
$ |
— |
|
$ |
68,121 |
|
COST OF GOODS SOLD |
|
|
28,313 |
|
|
3,275 |
|
|
2,358 |
|
|
|
— |
|
|
|
— |
|
|
33,946 |
|
GROSS PROFIT |
|
|
31,441 |
|
|
2,061 |
|
|
673 |
|
|
|
— |
|
|
|
— |
|
|
34,175 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
22,818 |
|
|
2,887 |
|
|
1,113 |
|
|
|
3,075 |
|
|
|
2,444 |
|
|
32,337 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
|
991 |
|
|
|
1,776 |
|
|
2,767 |
|
General and administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
|
5,493 |
|
|
|
5,350 |
|
|
10,843 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
— |
|
|
— |
|
|
— |
|
|
|
(4,245 |
) |
|
|
— |
|
|
(4,245 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2022 (in thousands)
(unaudited) |
|
|
Sustain |
|
Launch |
|
Liquidate/Other |
|
Fixed Costs |
|
Stock-based compensation expense |
|
Total |
NET REVENUE |
|
$ |
54,164 |
|
$ |
1,625 |
|
$ |
10,537 |
|
|
$ |
— |
|
|
$ |
— |
|
$ |
66,326 |
|
COST OF GOODS SOLD |
|
|
25,350 |
|
|
943 |
|
|
9,841 |
|
|
|
— |
|
|
|
— |
|
|
36,135 |
|
GROSS PROFIT |
|
|
28,813 |
|
|
682 |
|
|
696 |
|
|
|
— |
|
|
|
— |
|
|
30,191 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
23,181 |
|
|
803 |
|
|
5,463 |
|
|
|
3,345 |
|
|
|
999 |
|
|
33,792 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
|
1,195 |
|
|
|
511 |
|
|
1,706 |
|
General and administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
|
8,937 |
|
|
|
1,433 |
|
|
10,370 |
|
Impairment loss on goodwill |
|
|
— |
|
|
— |
|
|
— |
|
|
|
90,921 |
|
|
|
— |
|
|
90,921 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
— |
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
3,118 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
— |
|
|
— |
|
|
— |
|
|
|
(774 |
) |
|
|
— |
|
|
(774 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2021 (in thousands)
(unaudited) |
|
|
Sustain |
|
Launch |
|
Liquidate/Other |
|
Fixed Costs |
|
Stock-based compensation expense |
|
Total |
NET REVENUE |
|
$ |
163,466 |
|
$ |
12,292 |
|
$ |
8,688 |
|
|
$ |
— |
|
|
$ |
— |
|
$ |
184,446 |
|
COST OF GOODS SOLD |
|
|
74,173 |
|
|
8,191 |
|
|
9,100 |
|
|
|
— |
|
|
|
— |
|
|
91,464 |
|
GROSS PROFIT |
|
|
89,293 |
|
|
4,101 |
|
|
(412 |
) |
|
|
— |
|
|
|
— |
|
|
92,982 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
67,046 |
|
|
6,415 |
|
|
43,963 |
|
|
|
13,891 |
|
|
|
4,968 |
|
|
96,716 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
|
3,340 |
|
|
|
3,880 |
|
|
7,220 |
|
General and administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
|
19,325 |
|
|
|
12,482 |
|
|
31,807 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
— |
|
|
— |
|
|
— |
|
|
|
(11,949 |
) |
|
|
— |
|
|
(11,949 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended September 30, 2022 (in thousands)
(unaudited) |
|
|
Sustain |
|
Launch |
|
Liquidate/Other |
|
Fixed Costs |
|
Stock-based compensation expense |
|
Total |
NET REVENUE |
|
$ |
146,207 |
|
$ |
3,804 |
|
$ |
16,257 |
|
|
$ |
— |
|
|
$ |
— |
|
$ |
166,268 |
|
COST OF GOODS SOLD |
|
|
65,358 |
|
|
2,096 |
|
|
13,663 |
|
|
|
— |
|
|
|
— |
|
|
81,118 |
|
GROSS PROFIT |
|
|
80,849 |
|
|
1,707 |
|
|
2,593 |
|
|
|
— |
|
|
|
— |
|
|
85,150 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and distribution |
|
|
63,295 |
|
|
1,971 |
|
|
9,661 |
|
|
|
9,477 |
|
|
|
4,228 |
|
|
88,632 |
|
Research and development |
|
|
— |
|
|
— |
|
|
— |
|
|
|
3,164 |
|
|
|
1,418 |
|
|
4,582 |
|
General and administrative |
|
|
— |
|
|
— |
|
|
— |
|
|
|
23,272 |
|
|
|
6,210 |
|
|
29,482 |
|
Impairment loss on goodwill |
|
|
— |
|
|
— |
|
|
— |
|
|
|
119,941 |
|
|
|
— |
|
|
119,941 |
|
Impairment loss on
intangibles |
|
|
— |
|
|
— |
|
|
— |
|
|
|
3,118 |
|
|
|
— |
|
|
3,118 |
|
Change in fair value of
contingent earn-out liabilities |
|
|
— |
|
|
— |
|
|
— |
|
|
|
(5,240 |
) |
|
|
— |
|
|
(5,240 |
) |
Investor Contact:
Ilya Grozovsky
Vice President of Investor Relations & Corp. Development
Aterian, Inc.
ilya@aterian.io
917-905-1699
Aterian (NASDAQ:ATER)
Historical Stock Chart
From Mar 2023 to Mar 2023
Aterian (NASDAQ:ATER)
Historical Stock Chart
From Mar 2022 to Mar 2023